Effect of surgery and radiotherapy on complete blood count, lymphocyte subsets and inflammatory response in patients with advanced oral cancer
- PMID: 29490633
- PMCID: PMC5831585
- DOI: 10.1186/s12885-018-4136-9
Effect of surgery and radiotherapy on complete blood count, lymphocyte subsets and inflammatory response in patients with advanced oral cancer
Abstract
Background: The immune system has a known role in the aetiology, progression and final treatment outcome of oral squamous cell cancers. The aim of this study was to evaluate the influence of radical surgery and radiotherapy on advanced oral squamous cell carcinoma blood counts, lymphocyte subsets and levels of acute inflammatory response markers.
Methods: Blood samples were obtained from 56 patients 5 days before and 10 days after surgery, 30 days and 1 year after radiotherapy. The whole blood count, lymphocyte subsets and inflammatory response markers (C-reactive protein, erythrocyte sedimentation rate, leukocyte count, expression of index CD64 and index CD163 on neutrophils and monocytes) were measured, statistically analysed and correlated with clinical treatment outcomes.
Results: The post-operative period was characterised by the onset of anaemia, thrombocytosis, lymphopenia with reduced B lymphocyte, T helper cell and NK cell counts, and a rise in acute phase reactants. Immediately after radiotherapy, the anaemia improved, the lymphopenia worsened, and thrombocyte levels returned to pre-treatment values. There was a drop in counts across the T and B cell lines, including a reduction in B lymphocytes, naïve and memory T cells with reduced CD4+ and CD8+ counts and a decreased CD4/CD8 ratio. One year after radiotherapy all the lymphocyte subsets remained depressed, the only exception being NK cells, whose levels returned to pre-treatment values.
Conclusions: We concluded that surgery resulted in a stronger acute phase response than radiotherapy, while radiotherapy caused a long-lasting reduction in lymphocyte counts. There was no correlation between any of the pre-treatment parameters and the clinical outcome.
Keywords: Lymphopenia; Oral cancer; Radiotherapy; Surgery; Treatment outcome.
Conflict of interest statement
Ethics approval and consent to participate
This study was reviewed and approved by the Slovenian National Medical Ethics Committee, Approval No. 69/06/07. Written informed consent was obtained from all participants.
Consent for publication
Not applicable
Competing interests
None declared
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
Similar articles
-
Aberrant Alteration of Circulating Lymphocyte Subsets in Small Cell Lung Cancer Patients Treated with Radiotherapy.Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211039948. doi: 10.1177/15330338211039948. Technol Cancer Res Treat. 2021. PMID: 34851203 Free PMC article.
-
Long-term immune dysfunction after radiotherapy to the head and neck area.Int Immunopharmacol. 2003 Aug;3(8):1093-1104. doi: 10.1016/S1567-5769(03)00013-4. Int Immunopharmacol. 2003. PMID: 12860166 Clinical Trial.
-
Dynamics of peripheral blood lymphocyte subpopulations in the acute and subacute phase of Legionnaires' disease.PLoS One. 2013 Apr 30;8(4):e62265. doi: 10.1371/journal.pone.0062265. Print 2013. PLoS One. 2013. PMID: 23646123 Free PMC article.
-
[Mechanisms of radiation-induced lymphopenia and therapeutic impact].Bull Cancer. 2020 Jul-Aug;107(7-8):813-822. doi: 10.1016/j.bulcan.2020.04.009. Epub 2020 May 22. Bull Cancer. 2020. PMID: 32451070 Review. French.
-
Lymphocyte-Sparing Radiotherapy: The Rationale for Protecting Lymphocyte-rich Organs When Combining Radiotherapy With Immunotherapy.Semin Radiat Oncol. 2020 Apr;30(2):187-193. doi: 10.1016/j.semradonc.2019.12.003. Semin Radiat Oncol. 2020. PMID: 32381298 Free PMC article. Review.
Cited by
-
Efficacy of curcumin for amelioration of radiotherapy-induced oral mucositis: a preliminary randomized controlled clinical trial.BMC Cancer. 2023 Apr 17;23(1):354. doi: 10.1186/s12885-023-10730-8. BMC Cancer. 2023. PMID: 37069504 Free PMC article. Clinical Trial.
-
Sequencing of chemotherapy in total neoadjuvant treatment for rectal cancer does not predict radiation-induced lymphopenia.Radiol Oncol. 2025 Jun 16;59(2):252-256. doi: 10.2478/raon-2025-0034. eCollection 2025 Jun 1. Radiol Oncol. 2025. PMID: 40544503 Free PMC article.
-
Hypofractionated radiotherapy with simultaneous integrated boost for localized prostate cancer patients: effects on immune system and prediction of toxicity.Front Immunol. 2024 Oct 28;15:1457839. doi: 10.3389/fimmu.2024.1457839. eCollection 2024. Front Immunol. 2024. PMID: 39530099 Free PMC article.
-
Prostate Cancer Survivors Present Long-Term, Residual Systemic Immune Alterations.Cancers (Basel). 2022 Jun 22;14(13):3058. doi: 10.3390/cancers14133058. Cancers (Basel). 2022. PMID: 35804830 Free PMC article.
-
Multifunctional nanoparticle potentiates the in situ vaccination effect of radiation therapy and enhances response to immune checkpoint blockade.Nat Commun. 2022 Aug 23;13(1):4948. doi: 10.1038/s41467-022-32645-x. Nat Commun. 2022. PMID: 35999216 Free PMC article.
References
-
- Amit M, Yen TC, Liao CT, Chaturvedi P, Agarwal JP, Kowalski LP, Ebrahimi A, Clark JR, Kreppel M, Zoller J, et al. Improvement in survival of patients with oral cavity squamous cell carcinoma: an international collaborative study. Cancer. 2013;119(24):4242–4248. doi: 10.1002/cncr.28357. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials